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Clinical Significance 
- Both inflammation and elevated nutritional risk (as assessed by the Nutritional Risk 
Screening 2002) were independently associated with hypoalbuminemia in acutely ill 
patients. 
- At time of admission all of the three parameters namely inflammation, elevated 
nutritional risk, and hypoalbuminemia were independently associated with all-cause 
30-day mortality. 
- Combining these three parameters for the initial evaluation of a patient improved risk 
stratification. 
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Abstract 
Background 
Low serum albumin levels resulting from inflammation-induced capillary leakage or disease-
related anorexia during acute illness are associated with poor outcomes. We investigated the 
relationship of nutritional status and inflammation with low serum albumin levels and 30-day 
mortality in a large cohort. 
Methods 
We prospectively enrolled adult patients in the medical emergency department of a Swiss 
tertiary care center and investigated associations of C-reactive protein (CRP) and Nutritional 
Risk Screening (NRS 2002) as markers of inflammation and poor nutritional status, 
respectively, with low serum albumin levels and mortality using multivariate regression 
analyses. 
Results 
Of 2,465 patients, 1,019 (41%) had low serum albumin levels (<34 g/L), 619 (25.1%) had 
increased nutritional risk (NRS 2002 ≥3), and 1,086 (44.1%) had CRP values >20mg/L. 
Multivariate analyses adjusted for age, gender, diagnosis, and comorbidities revealed 
elevated CRP values (adjusted odds ratio [OR] 10.51, 95% confidence intervals [CI] 7.51 to 
14.72, P<0.001) and increased malnutrition risk (adjusted OR 2.87, 95% CI 1.98 to 4.15, 
P<0.001) to be associated with low serum albumin levels, even adjusting for both 
parameters. Low serum albumin levels, elevated CRP values, and increased nutritional risk 
independently predicted 30-day mortality, with areas under the curve (AUCs) of 0.77, 0.70, 
and 0.75, respectively. Combination of these three parameters showed an AUC of 0.82 to 
predict mortality. 
Conclusions 
Elevated parameters of inflammation and high nutritional risk were independently associated 
with hypoalbuminemia. All three parameters independently predicted mortality. Combining 
them during initial evaluation of patients in emergency departments facilitates mortality risk 
stratification. 
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Introduction 
Hypoalbuminemia is common in hospitalized patients and is associated with adverse clinical 
outcomes. Increased mortality was documented in patients with low serum albumin levels in 
both hospital 1-3 and community settings 4. Serum albumin has been broadly used as a 
diagnostic marker for malnutrition in clinical practice since 1979 when Seltzer et al first 
proposed serum albumin as one of two components—the other being total lymphocyte 
count—forming the basis of an instant nutritional assessment 5. Low serum albumin levels 
were initially thought to result from protein malnutrition or “kwashiorkor-like” malnutrition 6. 
However, in the last 20 years, the relevance of serum albumin as a specific nutritional marker 
has been questioned 7-9. Many different factors affect serum albumin levels, and it has been 
shown to lack sensitivity and specificity as an indicator of nutritional status 8,10. Specifically, 
acute and chronic inflammatory conditions affect serum albumin levels by altering hepatic 
protein metabolism and inducing capillary leakage 10-12. This being the case, serum albumin 
is not anymore considered a reliable nutritional marker in inflammatory states but rather a 
marker for disease severity 13,14. 
 
The role of albumin in non-inflammatory states is also in dispute since it is possible to die of 
starvation with normal serum albumin levels 9,14.  
 
In view of the above findings, the international Societies of Clinical Nutrition and Metabolism 
(European Society of Clinical Nutrition and Metabolism [ESPEN] and American Society of 
Clinical Nutrition and Metabolism [ASPEN]) no longer recommend assessment of serum 
albumin or any other biomarkers to identify and document adult malnutrition, choosing 
instead to focus on “insufficient energy intake”, weight loss, anthropometric as well as 
functional measures 13. In the absence of a broad accepted definition of malnutrition several 
nutritional screening tools as the validated Nutritional Risk Screening (NRS 2002) have been 
developed 15. 
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Despite these facts, many clinicians still believe that hypoalbuminemia is indicative of 
impaired nutritional status. Not surprisingly, serum albumin continues to be used as a marker 
of nutritional status, even in recent investigations 16-18. In an attempt to shed more light on 
this topic, we investigated whether inflammation or poor nutritional status affect serum 
albumin levels in a large cohort of unselected adult patients seeking emergency medical 
care. Furthermore, we investigated whether inflammation, nutritional risk, and low serum 
albumin levels were independently associated with mortality. 
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Materials and Methods 
Study design and study population 
This report presents the findings of secondary analysis of data from a prospective, 
observational, multicenter, multinational trial (the “TRIAGE” Study) that aimed to optimize 
triage and anticipate the post-acute care needs of adult patients seeking emergency medical 
care 19. The TRIAGE trial included consecutive patients seen in the emergency department 
(ED) of three tertiary care hospitals in Paris (France), Switzerland (Aarau), and the USA 
(Clearwater, Florida) between March 2013 and February 2014. The Institutional Review 
Boards of the three centers approved the study and waived the need for informed consent 
since this secondary analysis was an observational quality control study. The main study was 
registered at ClinicalTrials.gov (NCT01768494).  
This analysis included only adult inpatients of the Swiss center (Kantonsspital Aarau) 
seeking ED care for an acute medical illness. Of 3.586 patients, 1,121 were excluded due to 
missing data for either serum albumin, CRP, or parameters of the NRS 2002. 2,465 patients 
were included in the final analysis.  
 
Assessment of nutritional status and definition of nutritional impairment 
Nutritional status was assessed within 48 hours of hospital admission using the validated 
NRS 2002 tool in a bedside patient interview as recommended 20. Patients with an NRS 2002 
score of 3 points were considered at risk for malnutrition, as proposed in the original 
publication 15.  
 
Research objective and outcome measures 
The objective of this analysis was to investigate the interaction of nutritional status and 
inflammation with serum albumin levels. Therefore, the primary endpoint was the association 
of nutritional status (assessed by the NRS 2002) and inflammation (represented by CRP 
values) with serum albumin levels. Secondary endpoints were associations of inflammation 
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(represented by CRP values), nutritional risk (represented by NRS 2002 total scores), and 
low serum albumin levels, respectively, with all-cause 30-day mortality. 
 
Statistical analysis 
Patient characteristics were expressed using descriptive statistics including mean with 
standard deviation (SD), median with interquartile range (IQR), and frequencies, as 
appropriate. Frequency comparison was done using the 2 test, while correlations were 
assessed by Pearson rank correlation coefficients. 
We used multivariate logistic regression with stepwise adjustment for important confounders 
(age, sex, comorbidities, and main medical diagnosis) to investigate associations with 
outcomes. We used receiver operating statistics, reporting area under the curve (AUC) as a 
measure of discrimination. We repeated analyses in predefined subgroups.  
All tests were two-tailed and carried out at 5% significance levels. Analyses were performed 
with STATA 12.1 (Stata Corp., College Station, TX, USA). 
Detailed information regarding Materials and Methods are provided in the supplementary 
material. 
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Results 
Study population 
Overall, 2,465 patients with complete admission values for serum albumin, CRP, and NRS 
2002 parameters were included in the final analysis. The median age was 71 years and 
43.7% of patients were female. The median serum albumin concentration was 35.2 g/L. 
Overall, 1,019 (41%) patients had low serum albumin levels (<34 g/L), 619 (25.1%) were 
nutritionally at risk with NRS 2002 scores of 3 points (333, 13.5%) or higher (286, 11.6%), 
while 589 (23.9%) patients had low to moderately elevated CRP values (5.01 to 20 mg/L) 
and 1,086 (44.1%) patients had markedly elevated CRP values (>20mg/L). 
 
Compared to patients with normal serum albumin levels, patients with low serum albumin 
levels were older (72 y vs 70 y, P<0.001), were more often at nutritional risk (37.1% vs 
16.7%, P<0.001), and had significantly higher CRP values (median values of 67 mg/L vs 6 
mg/L, P<0.001). 
 
Additional baseline characteristics of the overall population, stratified by admission serum 
albumin values, and by survival status are shown in Table 1. 
 
Interaction of inflammation, nutritional risk, and low serum albumin 
We found a significant negative correlation of serum albumin with CRP (Spearman’s ρ −0.62, 
P<0.001). Furthermore, we found a significant but weaker negative correlation of serum 
albumin with NRS 2002 total scores (Spearman’s ρ −0.33, P<0.001) and a positive 
correlation between higher CRP values and higher NRS 2002 total scores (Spearman’s ρ 
0.24, P<0.001) (Fig. 1). 
 
Univariate regression analyses revealed that the frequency of hypoalbuminemia was more 
than 2.5 times higher in patients with mild to moderate elevated CRP values (5.01 to 20 
mg/L) compared to those with normal CRP values (32.4% vs 12.7%), corresponding to an 
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OR of 3.31 (95% CI 2.52 to 4.34, P<0.001) and more than 5 times higher in patients with 
markedly elevated CRP values (>20 mg/L) compared to those with normal CRP values 
(67.0% vs 12.7%), corresponding to an OR of 14.03 (95% CI 10.98 to 17.93, P<0.001). 
 
When associations of high nutritional risk and low serum albumin levels were examined, we 
found that occurrence of hypoalbuminemia in patients with an NRS 2002 total score of 3 
points was increased by 50% compared to those with a score <3 points (53.8% vs 34.7%), 
corresponding to a univariate OR of 2.19 (95% CI 1.73 to 2.77, P<0.001). The frequency of 
hypoalbuminemia doubled in patients with an NRS 2002 total score >3 points compared to 
those with a score <3 (69.6% vs 34.7%), corresponding to a univariate OR of 4.30 (95% CI 
3.28 to 5.63, P<0.001). 
 
After stepwise adjustment for important confounders (age, gender, comorbidities, and main 
diagnosis), both elevated CRP values and elevated nutritional risk remained significantly 
associated with depressed serum albumin levels, with fully adjusted ORs of 9.96 (95% CI 
7.10 to 13.98, P<0.001) and 2.40 (95% CI 1.62 to 3.54, P<0.001), respectively (Table 2). 
 
The ROC statistics for the prediction of hypoalbuminemia showed a higher predictive value 
for CRP values (AUC of 0.81; 95% CI 0.79 to 0.82) than for NRS 2002 total scores (AUC of 
0.65; 95% CI 0.62 to 0.67). Combination of both parameters showed minimal to no 
improvement for the prediction of depressed serum albumin levels (AUC 0.82; 95% CI 0.80 
to 0.84) (Table 2, Fig. 2A). 
 
Associations of inflammation, nutritional risk, and low serum albumin with mortality 
Of the included 2,465 patients, 205 (8.3%) had died by follow up 30 days after admission. 
Mortality was 4.5 times higher in patients with hypoalbuminemia compared to those with 
normal serum albumin levels (15.4% vs 3.3%), 5 times higher in patients with CRP values 
>20 mg/L compared to patients with normal CRP values (<5 mg/L) (13.4% vs 2.5%), and 
         
 12 
more than 6 times higher in patients with NRS 2002 total scores >3 points compared to those 
with NRS 2002 scores <3 points (26.6% vs 4.2%). 
 
In adjusted regression analyses, all three parameters (i.e., hypoalbuminemia, CRP values, 
and NRS 2002 scores) were significantly and independently associated with mortality, with 
corresponding fully adjusted ORs of 2.87 (95% CI 1.70 to 4.84, P<0.001) for 
hypoalbuminemia (<34 g/L vs normal), 3.23 (95% CI 1.52 to 6.87, P=0.002) for CRP 
(>20mg/L vs normal), and 4.56 (95% CI 2.75 to 7.58, P<0.001) for NRS 2002 total scores 
(>3 points vs <3 points) (Table 3). 
 
The ROC statistics showed low serum albumin levels, increased CRP values, and higher 
NRS 2002 total scores to be independent predictors of 30-day mortality, with AUCs of 0.77 
(95% CI 0.74 to 0.81), 0.70 (95% CI 0.66 to 0.73), and 0.75 (95% CI 0.72 to 0.79), 
respectively. A combined model including these three parameters revealed an AUC of 0.82 
(95% CI 0.79 to 0.84) to predict mortality (Table 3, Fig. 2B). 
 
Subgroup analyses 
Subgroup analyses are shown in the appendix (Figs. A1 and A2). Associations of nutritional 
risk and inflammation, respectively, with hypoalbuminemia were similar irrespective of CRP 
values, NRS 2002 total scores, and main diagnoses leading to hospitalization (Figs. A1A and 
A1B). 
We also found no difference with regard to associations of hypoalbuminemia, elevated 
nutritional risk, and different states of inflammation, respectively, with mortality in subgroups 
stratified by CRP values, NRS 2002 scores, serum albumin levels, and main diagnoses 
leading to hospitalization (Figs. A2A to A2C). 
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Discussion 
The main findings of this study are threefold. First, we found low serum albumin levels, 
elevated nutritional risk, and elevated CRP values to be frequently seen in a large cohort of 
unselected medical inpatients at time of admission. Second, we found both inflammation and 
elevated nutritional risk to be independently associated with hypoalbuminemia. Finally, we 
found low serum albumin levels, elevated CRP values, and nutritional risk to be independent 
predictors of mortality. 
 
Prevalence of hypoalbuminemia at time of admission in our cohort (41%) was similar to that 
reported in an Italian study (46.5%) investigating prevalence of hypoalbuminemia in an 
internal medicine department 23, but was higher than the 29% found in a large Israeli study 
also investigating patients admitted to the medical ward 1. This discrepancy could be due to 
differences in healthcare systems. In our study, mortality in patients with hypoalbuminemia at 
admission (15.4%) was also consistent with findings of other investigations that reported 
mortality rates between 14.0% and 16.3% among hospitalized patients 1-3. 
 
Whether serum albumin levels in sick patients are influenced mainly by inflammation or by 
malnutrition has long been discussed. Most of the existing evidence suggest that serum 
albumin is not an appropriate parameter to determine the nutritional status 24 and that 
changes in acute phase proteins such as serum albumin and prealbumin do not reflect poor 
nutritional status but rather the severity of inflammation and illness in acute disease 8,25-27. In 
our study, we confirm that inflammation is associated with hypoalbuminemia. This is 
explained by underlying processes in inflammation, wherein serum albumin levels decrease 
due to several mechanisms 8,27,28. 
 
Further, we found an association of nutritional risk with low serum albumin values, 
independent of the inflammatory status. This is in line with findings of a few recent 
investigations in which serum albumin is still considered a suitable marker to identify 
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malnutrition in patients after heart transplantation 17, and before orthopedic surgery 16. 
Another article notes the value of serum albumin as a nutritional screening marker in 
maintenance dialysis patients 18. Authors emphasize low cost and easy availability of serum 
albumin as a screening marker as compared to other nutritional assessment which generally 
require extensive training and clinical skills. 
 
In contrast, investigations in healthy individuals suggest that in states of starvation, serum 
albumin has no value as a marker to identify malnourished patients and their need for 
feeding. In a recent systematic review, serum albumin levels failed to identify subjects with 
severe protein-energy malnutrition until states of obvious starvation (e.g., BMI below 12 
kg/m2 or prolonged fasting) had been reached 9. This is in line with a study of The Academy 
of Nutrition and Dietetics Evidence Analysis Library (EAL) that did not find a consistent 
change in serum albumin levels with weight loss or caloric restriction 29. However, our results 
indicate that at least in individuals experiencing acute diseases, elevated nutritional risk 
seems to have an impact on serum albumin levels, independent of the inflammatory state. 
 
Our results further indicate that hypoalbuminemia, elevated nutritional risk, and elevated 
CRP values are independent predictors of mortality. Interestingly, combining the three 
parameters namely serum albumin levels, CRP values, and NRS 2002 total scores for the 
initial evaluation of patients even improved risk stratification. 
 
Our finding of heightened nutritional risk (evaluated using the NRS 2002 tool) as a mortality 
predictor is in line with findings of a large Polish study in which the in-hospital mortality rate in 
patients with NRS 2002 total scores 3 points (19.7%) was similar to the 30-day mortality 
rate (20.7%) in our patients with elevated risk of malnutrition 30. 
 
As for the association of serum albumin levels with mortality, our findings are in line with the 
results of a meta-analysis 31 indicating an association between hypoalbuminemia and 
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mortality that was independent of both nutritional status and inflammation. However, there 
was no standardized nutritional assessment in the studies included in the meta-analysis, and 
different nutritional indices such as BMI, body weight, body fat percentage, and midarm 
circumference had been used. To the best of our knowledge, the present study is the first to 
show an association of serum albumin levels with mortality independent of both inflammation 
and nutritional risk as assessed by NRS 2002. 
 
Our study has a few limitations. First, as a secondary analysis of data from a previous trial, 
the results are primarily hypothesis generating. Confounding between the crude associations 
of serum albumin levels, CRP values, and nutritional risk is likely, although we did address 
this limitation by adjusting for important confounders. Second, due to exclusion of about one 
third of the patients there is the possibility of a selection bias. However, patient 
characteristics of the excluded patients were comparable to those included (Table A1). Third, 
we assessed laboratory parameters and nutritional risk only at the time of admission and did 
not record nutritional interventions such as use of nutritional (oral) supplements. Thus, we 
were not able to demonstrate whether improvement of nutritional status or changes in 
laboratory parameters translate into better clinical outcomes. Fourth, besides the NRS 2002, 
we did not perform an additional detailed assessment of patients’ nutritional status. Not all 
patients with increased nutritional risk may have clinically overt malnutrition and may have 
been missed by the NRS 2002 tool. However, it is an extensively used evidence-based 
screening tool that has been thoroughly validated 21,22 and is recommended by the ESPEN 
as a suitable tool for screening adult inpatients 8,20. The NRS 2002 was found to have a 
positive predictive value of 79 to 85% for the prediction of undernutrition in hospitalized 
patients 21,32,33. Finally, acute inflammatory disease contributes to higher NRS 2002 total 
scores, as one part of the score is influenced by the severity of illness (stress metabolism). 
Thus, there is the possibility of some kind of interaction between NRS 2002 total scores and 
inflammation. 
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Conclusions 
This prospective study that included medical patients upon ED admission found elevated 
parameters of inflammation as well as nutritional risk to be independently associated with 
hypoalbuminemia. This suggests that both inflammation and nutritional risk contribute to low 
serum albumin levels in acutely ill patients. However, the impact of inflammation seems to be 
stronger. All three parameters namely hypoalbuminemia, high CRP values, and NRS 2002 
total scores 3 were independent predictors of mortality. Combining these parameters for the 
initial evaluation of a patient thus facilitates improved risk stratification. 
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Figures 
 
 
Figure 1 Correlations of serum albumin and inflammation (log CRP) including graphical 
regression (panel A), serum albumin and nutritional risk (NRS 2002 total scores; panel B), 
and inflammation (log CRP) and nutritional risk (NRS 2002 total scores; panel C). 
 
A. 
 
 
B. 
 
C. 
 
Figure 2 ROC statistics (AUC) of CRP values and NRS 2002 scores for the prediction of low 
serum albumin levels (panel A). ROC statistics (AUC) of CRP values, NRS 2002 scores, and 
serum albumin levels for the prediction of mortality (panel B). 
 
A. 
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B. 
 
 
AUC, area under the curve; CRP, C-reactive protein; NRS, Nutritional Risk Screening 2002; 
ROC, receiver operating characteristic. 
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Tables 
 
Table 1 Baseline characteristics of the entire cohort, stratified by admission serum albumin levels, and stratified by vital status 30 days after 
admission 
 
  Total cohort Serum albumin ≥34 g/L Serum albumin <34 g/L P value Survivors Non-survivors P value 
Number of Patients, n 2465 1446 1019 
 
2260 205 
 
Socio-demographics 
       Female gender, n (%) 1076 (43.7%) 635 (43.9%) 441 (43.3%) 0.75 998 (44.2%) 78 (38.0%) 0.091 
Age, median (IQR) 71 (60, 80) 70 (56, 80) 72 (63, 80) <0.001 71 (59, 79) 76 (68, 84) <0.001 
Vital signs, median (IQR) 
       Blood pressure systolic (mmHg) 138.5 (121, 155) 145 (127, 161) 130 (112, 147) <0.001 139 (122, 156) 129 (112, 148) <0.001 
Blood pressure diastolic (mmHg) 80 (69, 90) 83 (73, 94) 74 (65, 86) <0.001 80 (70, 91) 74 (65, 87) <0.001 
Pulse rate (bpm) 85 (72, 100) 82 (69, 95) 89 (77, 105) <0.001 84 (71, 99) 90 (77, 109) <0.001 
SpO2 (%) 95 (93, 97) 96 (93, 97) 94 (91, 97) <0.001 95 (93, 97) 94 (91, 96) <0.001 
Temperature (°C) 37.0 (36.6, 37.6) 36.9 (36.5, 37.3) 37.2 (36.7, 38.0) <0.001 37.0 (36.6, 37.6) 37.1 (36.6, 37.7) 0.74 
Nutritional risk screening, n (%) 
        NRS 2002 <3 1846 (74.9%) 1205 (83.3%) 641 (62.9%) <0.001 1769 (78.3%) 77 (37.6%) <0.001 
 NRS 2002 =3 333 (13.5%) 154 (10.7%) 179 (17.6%) 
 
281 (12.4%) 52 (25.4%) 
  NRS 2002 >3 286 (11.6%) 87 (6.0%) 199 (19.5%) 
 
210 (9.3%) 76 (37.1%) 
 Main diagnosis, n (%) 
       Cardiovascular disease 684 (27.7%) 495 (34.2%) 189 (18.5%) <0.001 657 (29.1%) 27 (13.2%) <0.001 
Digestive tract disease 263 (10.7%) 134 (9.3%) 129 (12.7%) 0.007 248 (11.0%) 15 (7.3%) 0.10 
Immune disorder 49 (2.0%) 29 (2.0%) 20 (2.0%) 0.94 49 (2.2%) 0 (0.0%) 0.033 
Infectious disease 447 (18.1%) 193 (13.3%) 254 (24.9%) <0.001 414 (18.3%) 33 (16.1%) 0.43 
Metabolic disorder 63 (2.6%) 43 (3.0%) 20 (2.0%) 0.12 59 (2.6%) 4 (2.0%) 0.57 
Miscellaneous 88 (3.6%) 47 (3.3%) 41 (4.0%) 0.31 83 (3.7%) 5 (2.4%) 0.36 
Musculoskeletal disorder 103 (4.2%) 65 (4.5%) 38 (3.7%) 0.35 99 (4.4%) 4 (2.0%) 0.096 
Neurologic disorder 255 (10.3%) 214 (14.8%) 41 (4.0%) <0.001 236 (10.4%) 19 (9.3%) 0.60 
Psychological disorder 59 (2.4%) 44 (3.0%) 15 (1.5%) 0.012 58 (2.6%) 1 (0.5%) 0.062 
Pulmonary disease 133 (5.4%) 71 (4.9%) 62 (6.1%) 0.20 123 (5.4%) 10 (4.9%) 0.73 
Tumor 292 (11.8%) 90 (6.2%) 202 (19.8%) <0.001 206 (9.1%) 86 (42.0%) <0.001 
Comorbidities, n (%) 
       Chronic heart failure 199 (8.1%) 97 (6.7%) 102 (10.0%) 0.003 177 (7.8%) 22 (10.7%) 0.14 
Chronic renal failure 445 (18.1%) 217 (15.0%) 228 (22.4%) <0.001 398 (17.6%) 47 (22.9%) 0.058 
COPD 147 (6.0%) 72 (5.0%) 75 (7.4%) 0.014 127 (5.6%) 20 (9.8%) 0.017 
Coronary heart disease 275 (11.2%) 208 (14.4%) 67 (6.6%) <0.001 259 (11.5%) 16 (7.8%) 0.110 
Diabetes mellitus 342 (13.9%) 198 (13.7%) 144 (14.1%) 0.76 321 (14.2%) 21 (10.2%) 0.12 
Hypertension 1248 (50.6%) 789 (54.6%) 459 (45.0%) <0.001 1168 (51.7%) 80 (39.0%) <0.001 
Stroke 183 (7.4%) 132 (9.1%) 51 (5.0%) <0.001 161 (7.1%) 22 (10.7%) 0.059 
Tumor 378 (15.3%) 144 (10.0%) 234 (23.0%) <0.001 307 (13.6%) 71 (34.6%) <0.001 
Blood markers, median (IQR) 
       Serum albumin, (g/L) 35.2 (30.8, 38.5) 37.9 (36.0, 40.1) 29.9 (26.4, 32.1) <0.001 35.7 (31.5, 38.8) 28.6 (23.4, 33.8) <0.001 
Hemoglobin, (g/L) 131 (111, 145) 138 (126, 150) 115 (99, 131) <0.001 132 (113, 145) 115 (99, 132) <0.001 
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Markers of inflammation 
       CRP continuous (mg/L) 14 (0. 75) 6 (0, 20) 67 (16, 147) <0.001 12 (0, 66) 64 (16, 150) <0.001 
CRP <5mg/L, n (%) 790 (32.1%) 690 (47.7%) 100 (9.8%) <0.001 770 (34.1%) 20 (9.8%) <0.001 
CRP 5.01 - 20 mg/L, n (%) 589 (23.9%) 398 (27.5%) 191 (18.7%) 
 
549 (24.3%) 40 (19.5%) 
 CRP >20 mg/L, n (%) 1086 (44.1%) 358 (24.8%) 728 (71.4%) 
 
941 (41.6%) 145 (70.7%) 
 PCT continuous (mg/L) .19 (.11, .51) .14 (.09, .24) .255 (.13, .925) <0.001 .18 (.11, .485) .29 (.15, .87) <0.001 
White blood cells (G/L) 9.0 (6.8, 12.1) 8.4 (6.7, 10.9) 9.9 (7.1, 13.5) <0.001 8.9 (6.8, 11.9) 9.9 (7.0, 14.6) 0.007 
Kidney markers 
       Creatinine (µmol/L) 95 (76, 126) 92 (75, 114) 101 (78, 150) <0.001 94 (76, 124) 107 (74, 163) 0.007 
Urea (mmol/L) 6.9 (5, 10.5) 6.5 (4.8, 9.1) 7.8 (5.3, 13.2) <0.001 6.8 (5, 10.1) 9.6 (5.9, 14.9) <0.001 
 
COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IQR, interquartile range; NRS 2002, Nutritional Risk Screening 2002; 
PCT, Procalcitonin. 
Blood markers represent values at time of admission. 
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Table 2 Regression analyses for associations of inflammation (CRP) and nutritional risk (NRS 2002) with hypoalbuminemia. Receiver operating 
characteristics (AUC) for the prediction of hypoalbuminemia 
 
Parameter 
Events, n (%) Regression analyses, OR (95% CI), P value 
AUC (95% CI) 
30-day Mortality 
Serum albumin 
<34 g/L 
Serum albumin 
≥34 g/L 
Unadjusted Model 1 Model 2 Model 3  
CRP (mg/L) 
        
5 20 (2.5%) 100 (12.7%) 690 (87.3%) Ref. Ref. Ref. Ref. 
 
5.01–20.0 40 (6.8) 191 (32.4%) 398 (67.6%) 3.31 (2.52, 4.34), P<0.001 3.18 (2.42, 4.18), P<0.001 2.69 (1.88, 3.83), P<0.001 2.61 (1.82, 3.73), P<0.001 
 
>20 145 (13.4) 728 (67.0%) 358 (33.0%) 14.03 (10.98, 17.93), P<0.001 13.86 (10.83, 17.73), P<0.001 10.51 (7.51, 14.72), P<0.001 9.96 (7.10, 13.98), P<0.001 
 
Continuous 
   
6.59 (5.65, 7.70), P<0.001 6.64 (5.67, 7.76), P<0.001 6.03 (4.84, 7.52), P<0.001 5.78 (4.62, 7.22), P<0.001 0.81 (0.79 to 0.82) 
NRS 2002 (points) 
       
<3 77 (4.2) 641 (34.7%) 1205 (65.3%) Ref. Ref. Ref. Ref. 
 
3 52 (15.6) 179 (53.8%) 154 (46.2%) 2.19 (1.73, 2.77), P<0.001 2.01 (1.58, 2.55), P<0.001 1.67 (1.22, 2.30), P=0,001 1.51 (1.07, 2.13), P=0,018 
 
>3 76 (26.6) 199 (69.6%) 87 (30.4%) 4.30 (3.28, 5.63), P<0.001 4.07 (3.10, 5.33), P<0.001 2.87 (1.98, 4.15), P<0.001 2.40 (1.62, 3.54), P<0.001 
 
Continuous 
   
1.55 (1.45, 1.66), P<0.001 1.52 (1.41, 1.63), P<0.001 1.40 (1.28, 1.54), P<0.001 1.33 (1.19, 1.47), P<0.001 0.65 (0.62 to 0.67) 
Combined 
(CRP & NRS)        
0.82 (0.80 to 0.84) 
Adjustments: Model 1: age and sex; Model 2: age, sex, comorbidities, and main diagnosis; Model 3: fully adjusted for age, sex, comorbidities, 
main diagnosis, and CRP/NRS 2002. 
 
For regression analysis with continuous values, CRP was log transformed with a base of ten before entering into statistical models. 
Therefore, the ORs correspond to a tenfold increase in CRP values. 
 
95% CI, 95% confidence interval; AUC, area under the curve; CRP, C-reactive protein; NRS 2002, Nutritional Risk Screening 2002; OR, 
odds ratio; Ref, reference. 
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Table 3 Regression analyses for associations of serum albumin, inflammation (CRP), and 
nutritional risk (NRS 2002) with mortality, respectively. Receiver operating characteristics 
(AUC) for the prediction of mortality 30 days after admission 
 
Parameter 
Events, n (%) Regression analyses, OR (95% CI), P value 
AUC (95% CI) 30-day 
Mortality 
Unadjusted Model 1 Model 2 Model 3 
Serum 
albumin (g/L)       
≥34 48/1446 (3.3) Ref. Ref. Ref. Ref. 
 
<34 
157/1019 
(15.4) 
5.30 (3.80, 7.41), P 
<0.001 
4.89 (3.50, 6.85), P 
<0.001 
4.61 (2.83, 7.50), P 
<0.001 
2.87 (1.70, 4.84), P 
<0.001  
Continuou
s  
0.85 (0.83, 0.87), P 
<0.001 
0.85 (0.83, 0.87), P 
<0.001 
0.84 (0.81, 0.88), P 
<0.001 
0.88 (0.84, 0.92), P 
<0.001 
0.77 (0.74 to 0.81) 
CRP (mg/L) 
      
5 20/790 (2.5) Ref. Ref. Ref. Ref. 
 
5.01–20.0 40/589 (6.8) 
2.81 (1.62, 4.85), P 
<0.001 
2.57 (1.48, 4.46), P 
=0.001 
2.75 (1.31, 5.80), P 
=0.008 
2.29 (1.04, 5.01), P 
=0.039  
>20 
145/1086 
(13.4) 
5.93 (3.68, 9.56), P 
<0.001 
5.50 (3.41, 8.89), P 
<0.001 
5.86 (2.91, 11.79), P 
<0.001 
3.23 (1.52, 6.87), P 
=0.002  
Continuou
s  
2.81 (2.25, 3.52), P 
<0.001 
2.83 (2.24, 3.56), P 
<0.001 
3.26 (2.26, 4.69), P 
<0.001 
1.59 (1.04, 2.44), P 
=0.032 
0.70 (0.66 to 0.73) 
NRS 2002 (points) 
     
<3 77/1846 (4.2) Ref. Ref. Ref. Ref. 
 
3 52/333 (15.6) 
4.25 (2.93, 6.18), P 
<0.001 
3.66 (2.50, 5.35), P 
<0.001 
3.73 (2.26, 6.15), P 
<0.001 
3.25 (1.94, 5.42), P 
<0.001  
>3 76/286 (26.6) 
8.31 (5.87, 11.77), P 
<0.001 
7.61 (5.34, 10.84), P 
<0.001 
5.81 (3.53, 9.56), P 
<0.001 
4.56 (2.75, 7.58), P 
<0.001  
Continuou
s   
1.94 (1.76, 2.14), P 
<0.001 
1.91 (1.73, 2.12), P 
<0.001 
1.71 (1.49, 1.97), P 
<0.001 
1.50 (1.29, 1.74), P 
<0.001 
0.75 (0.72 to 0.79) 
Combined 
(serum 
albumin, 
CRP, NRS 
2002) 
     
0.82 (0.79 to 0.84) 
Adjustments: Model 1: age and sex; Model 2 age, sex, comorbidities, and main diagnosis; 
Model 3: fully adjusted for age, sex, comorbidities, main diagnosis, and serum 
albumin/CRP/NRS 2002. 
 
For regression analysis with continuous values, CRP was log transformed with a base of ten 
before entering into statistical models. Therefore, the ORs correspond to a tenfold increase 
in CRP values. 
 
95% CI, 95% confidence interval; AUC, area under the curve; CRP, C-reactive protein; NRS 
2002, Nutritional Risk Screening 2002; OR, odds ratio; Ref, reference. 
 
 
 
         
